Alexander F Zabudkin

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 7 EPO patents. Top assignees: Solux Corporation, Synbias Pharma Ag. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander F Zabudkin. Retrieved from https://idiyas.com/inventor/alexander-f-zabudkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 44.4

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Donetak, UA (2008)
Donetsk, UA (2006 - 2017)
Gerusbach, DE (2018)

Company Filing History:

Years Active: 2006-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10030043 - Method for the synthesis of clofarabine (2018-07-24),

2. 9765083 - Method for the synthesis of irinotecan (2017-09-19),

3. 9035032 - Method for preparing 4-demethyldaunorubicin (2015-05-19),

4. 8846882 - Method of producing 4-demethoxydaunorubicin (2014-09-30),

5. 8802830 - Synthesis of epirubicin from 13-dihydrodaunorubicine (2014-08-12),

6. 8357785 - Method of aralkylation of 4'-hydroxyl group of anthracylins (2013-01-22),

7. 7485707 - Thermally stable crystalline epirubicin hydrochloride and method of making the same (2009-02-03),

8. 7388083 - [object Object] (2008-06-17),

9. 7053191 - Method of preparing 4-R-substituted 4-demethoxydaunorubicin (2006-05-30),

Title: Alexander F Zabudkin: Innovator in Anticancer Drug Synthesis

Introduction

Alexander F Zabudkin is a notable inventor based in Donetsk, Ukraine. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of anticancer drugs. With a total of 9 patents to his name, his work has had a considerable impact on cancer treatment methodologies.

Latest Patents

Zabudkin's latest patents include innovative methods for synthesizing important anticancer compounds. One of his notable inventions is a method for the synthesis of clofarabine, which involves a high-yield production process. This method includes the preparation of 2-chloroadenosine through enzymatic transglycosylation, followed by several chemical transformations. Another significant patent is for the synthesis of irinotecan, which details a process for preparing 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin. This method highlights the selective ethylation of a precursor compound, showcasing Zabudkin's expertise in complex organic synthesis.

Career Highlights

Throughout his career, Zabudkin has worked with various companies that focus on pharmaceutical development. Notable among these are Solux Corporation and Synbias Pharma AG. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Zabudkin has collaborated with several professionals in his field, including Victor Matvienko and Aleksandr M Itkin. These collaborations have enriched his research and expanded the scope of his inventions.

Conclusion

Alexander F Zabudkin is a distinguished inventor whose work in the synthesis of anticancer drugs has made a significant impact on the pharmaceutical industry. His innovative methods and collaborations continue to advance the field of medicinal chemistry.

Profile summary based on public USPTO records.